Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2022;33(3):271-90
Article Links
Time to Deal with Rheumatoid Cachexia: Prevalence, Diagnostic Criteria, Treatment Effects and Evidence for Management
Elisavet Efthymiou1, Maria G. Grammatikopoulou1,2, Konstantinos Gkiouras2, Georgios Efthymiou2, Efterpi Zafiriou3, Dimitrios G. Goulis4, Lazaros I. Sakkas2, Dimitrios P. Bogdanos2
Authors Information

1Department of Nutritional Sciences & Dietetics, Faculty of Health Sciences, International Hellenic University, Alexander Campus, Sindos, Thessaloniki, Greece

2Department of Rheumatology and Clinical Immunology, Faculty of Medicine, University General Hospital of Larissa, School of Health Sciences, University of Thessaly, Larissa, Greece

3Department of Dermatology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, Larissa, Greece

4Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynaecology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece

MG Grammatikopoulou, K Gkiouras, G Efthymiou, E Zafiriou, DG Goulis, LI Sakkas, DP Bogdanos

Keywords: testosterone, hypogonadism, body cell mass, oral nutrient supplementation, methotrexate, disease activity, sarcopenia, DAS28, fat-free mass, body composition
References
  1. Torpy JM, Perazza GD, Golub RM. Rheumatoid Arthritis. JAMA 2011;305:1824-1824.
  2. Almutairi K, Nossent J, Preen D, Keen HI, Inderjeeth CA. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int 2021;41:863-77.
  3. Almutairi K, Nossent J, Preen D, Keen H, Inderjeeth C. SAT0576 The prevalence of rheumatoid arthitis:a systematic review of population-based studies. Ann Rheum Dis 2020;79:1246-1247.
  4. Turk SA, Van Schaardenburg D, Boers M, de Boer S, Fokker C, Lems WF, et al. An unfavorable body composition is common in early arthritis patients:A case control study. PLoS One 2018;13:e0193377.
  5. Lemmey AB. Rheumatoid cachexia:the undiagnosed, untreated key to restoring physical function in rheumatoid arthritis patients? Rheumatology 2016;55:1149-150.
  6. Book C, Karlsson MK, Åkesson K, Jacobsson LT. Early rheumatoid arthritis and body composition. Rheumatology 2009;48:1128-132.
  7. Gabdulina G, Tokarev A, Mussabaeva D. AB0347 Body composition in patients with rheumatoid arthritis kazakh nationality. Ann Rheum Dis 2018;77:1346-7.
  8. Toroptsova N, Dobrovolskaya O, Demin N, Shornikova L. AB0267 Body composition in patients with rheumatoid arthritis. Ann Rheum Dis 2020;79:1432.
  9. Westhovens R, Nijs J, Taelman V, Dequeker J. Body composition in rheumatoid arthritis. Br J Rheumatol 1997;36:444-8.
  10. Rall LC, Roubenoff R. Rheumatoid cachexia:metabolic abnormalities, mechanisms and interventions. Rheumatology 2004;43:1219-23.
  11. Moore FD. Energy and the maintenance of the body cell mass. JPEN J Parenter Enteral Nutr 1980;4:228-60.
  12. Roubenoff R, Roubenoff RA, Ward LM, Holland SM, Hellmann DB. Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol 1992;19:1505-10.
  13. Roubenoff R, Roubenoff RA, Cannon JG, Kehayias JJ, Zhuang H, Dawson-Hughes B, et al. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 1994;93:2379-86.
  14. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980;69:491-7.
  15. Kotler DP, Tierney AR, Wang J, Pierson RN Jr. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989;50:444-7.
  16. Metsios GS, Stavropoulos-Kalinoglou A, Koutedakis Y, Kitas GD. Rheumatoid Cachexia: causes, significance and possible interventions. Hosp Chronicles 2006;1:20-2.
  17. Santo RCE, Fernandes KZ, Lora PS, Filippin LI, Xavier RM. Prevalence of rheumatoid cachexia in rheumatoid arthritis:a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 2018;9:816-25.
  18. Engvall I-L, Elkan A-C, Tengstrand B, Cederholm T, Brismar K, Hafstrom I. Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin-like growth factor. Scand J Rheumatol 2008;37:321-8.
  19. Summers GD, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD. Rheumatoid cachexia and cardiovascular disease. Nat Rev Rheumatol 2010 68 2010;6:445-1.
  20. Stavropoulos-Kalinoglou A, Metsios GS, Koutedakis Y, Nevill AM, Douglas KM, Jamurtas A, et al. Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis 2007;66:1316-21.
  21. Walsmith J, Abad L, Kehayias J, Roubenoff R. Tumor necrosis factor-alpha production is associated with less body cell mass in women with rheumatoid arthritis. J Rheumatol 2004;31:23-9.
  22. Santillán-Díaz C, Ramírez-Sánchez N, Espinosa-Morales R, Orea-Tejeda A, Llorente L, Rodríguez-Guevara G, et al. Prevalence of rheumatoid cachexia assessed by bioelectrical impedance vector analysis and its relation with physical function. Clin Rheumatol 2018;37:607-14.
  23. Tierney M, Fraser A, Kennedy N. Physical activity in rheumatoid arthritis:a systematic review. J Phys Act Health 2012;9:1036-48.
  24. Metsios GS, Stavropoulos-Kalinoglou A, Douglas KMJ, Koutedakis Y, Nevill AM, Panoulas VF, et al. Blockade of tumour necrosis factor-alpha in rheumatoid arthritis:effects on components of rheumatoid cachexia. Rheumatology (Oxford) 2007;46:1824-7.
  25. Fenton SAM, van Zanten JJCSV, Duda JL, Metsios GS, Kitas GD. Sedentary behaviour in rheumatoid arthritis:definition, measurement and implications for health. Rheumatology (Oxford) 2018;57:213-26.
  26. Bravo Ramírez A, Hurtado Torres GF, Martínez Martínez M, Abud Mendoza C. Análisis de la composición corporal en mujeres adultas con lupus eritematoso sistémico. Nutr Hosp 2012;27:950-951.
  27. Tengstrand B, Carlström K, Hafström I. Bioavailable testosterone in men with rheumatoid arthritis—high frequency of hypogonadism. Rheumatology 2002;41:285-289.
  28. Baillargeon J, Al Snih S, Raji MA, Urban RJ, Sharma G, Sheffield-Moore M, et al. Hypogonadism and the risk of rheumatic autoimmune disease. Clin Rheumatol 2016;35:2987.
  29. Letarouilly J-G, Flipo R-M, Cortet B, Tournadre A, Paccou J. Body composition in patients with rheumatoid arthritis: a narrative literature review. Ther Adv Musculoskelet Dis 2021;13:1759720X211015006.
  30. Konijn NPC, van Tuyl LHD, Boers M, van de Ven PM, den Uyl D, Ter Wee MM, et al. The short-term effects of two high-dose, step-down prednisolone regimens on body composition in early rheumatoid arthritis. Rheumatology (Oxford) 2016;55:1615-22.
  31. Giles JT, Ling SM, Ferrucci L, Bartlett SJ, Andersen RE, Towns M, et al. Abnormal body composition phenotypes in older rheumatoid arthritis patients:association with disease characteristics and pharmacotherapies. Arthritis Rheum 2008;59:807-15.
  32. Ekici R, Erden A, Güven SC, Armağan B, Özdemir B, Karakaş Ö, et al. Prevalence of sarcopenia and clinical implications in patients with newly diagnosed rheumatoid arthritis. Nutrition 2021;90:111353.
  33. Lin J-Z, Chen C-T, Ma J-D, Mo YQ, Li QH, Chen LF, et al. Neglected extra-articular manifestations in rheumatoid arthritis patients with normal body mass index:reduced skeletal muscle overlapping overfat. Ther Adv Chronic Dis 2020;11:204062232097524.
  34. Lombard LA, du Plessis LM, Visser J. Body composition of rheumatoid arthritis patients in the City of Cape Town, South Africa. Clin Rheumatol 2014;33:467-76.
  35. van Bokhorst - de van der Schueren MAE, Konijn NPC, Bultink IEM, Lems WF, Earthman CP, van Tuyl LH. Relevance of the new pre-cachexia and cachexia definitions for patients with rheumatoid arthritis. Clin Nutr 2012;31:1008-10.
  36. El Maghraoui A, Sadni S, Rezqi A, Bezza A, Achemlal L, Mounach A. Does Rheumatoid Cachexia Predispose Patients with Rheumatoid Arthritis to Osteoporosis and Vertebral Fractures? J Rheumatol 2015;42:1556-62.
  37. Papichev E, Zavodovsky В, Seewordova L, Polyakova J, Akhverdyan Y. POS0509 Prevalence of rheumatoid cachexia and its association with serum fetuin-a levels in caucasian patients with rheumatoid arthritis. Ann Rheum Dis 2021;80:487-488.
  38. Ångström L, Hörnberg K, Sundström B, Södergren A. Rheumatoid cachexia in early rheumatoid arthritis: prevalence and associated variables. Scand J Rheumatol. Epub ahead of print 2021.
  39. Pineda-Juárez JA, Lozada-Mellado M, Ogata-Medel M, Hinojosa-Azaola A, Santillán-Díaz C, Llorente L, et al. Body composition evaluated by body mass index and bioelectrical impedance vector analysis in women with rheumatoid arthritis. Nutrition 2018;53:49-53.
  40. Müller R, Kull M, Põlluste K, Valner A, Lember M, Kallikorm R. Factors Associated With Low Lean Mass in Early Rheumatoid Arthritis: A Cross- Sectional Study. Medicina (Kaunas);55. Epub ahead of print 8 November 2019.
  41. Hugo M, Mehsen-Cetre N, Pierreisnard A, Schaeverbeke T, Gin H, Rigalleau V. Energy expenditure and nutritional complications of metabolic syndrome and rheumatoid cachexia in rheumatoid arthritis:an observational study using calorimetry and actimetry. Rheumatology (Oxford) 2016;55:1202-9.
  42. Murillo-Saich JD, Vazquez-Villegas ML, Ramirez-Villafaña M, Saldaña-Cruz AM, Aceves-Aceves JA, Gonzalez-Lopez L, et al. Association of myostatin, a cytokine released by muscle, with inflammation in rheumatoid arthritis:A cross-sectional study. Medicine (Baltimore) 2021;100:e24186.
  43. Metsios GS, Stavropoulos-Kalinoglou A, Panoulas VF, Sandoo A, Toms TE, Nevill AM, et al. Rheumatoid cachexia and cardiovascular disease. Clin Exp Rheumatol 2009;27:985-988.
  44. Elkan A-C, Håkansson N, Frostegård J, Cederholm T, Hafström I. Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis:a cross-sectional study. Arthritis Res Ther 2009;11:R37.
  45. Elkan A-C, Engvall I-L, Cederholm T, Hafström I. Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, Mini Nutritional Assessment and body composition techniques. Eur J Nutr 2009;48:315-22.
  46. Macaskill P, Gatsonis C, Deeks J, Harbord R, Takwoingi Y. Analysing and Presenting Results: Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. Version 1.0. ©The Cochrane Collaboration, 2010.
  47. Santo RC, Silva JM, Lora PS, Moro ALD, Freitas EC, Bartikoski BJ, et al. Cachexia in patients with rheumatoid arthritis: a cohort study. Clin Rheumatol. Epub ahead of print 23 May 2020. DOI:10.1007/s10067-020-05119-y.
  48. Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, et al. Cachexia: A new definition. Clin Nutr 2008;27:793-9.
  49. Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia:joint document elaborated by Special Interest Groups (SIG) ‘cachexia-anorexia in chronic wasting diseases’ and ‘nutrition in geriatrics’. Clin Nutr 2010;29:154-9.
  50. Sipilä S, Törmäkangas T, Sillanpää E, Aukee P, Kujala UM, Kovanen V, et al. Muscle and bone mass in middle-aged women: role of menopausal status and physical activity. J Cachexia Sarcopenia Muscle 2020;11:698-709.
  51. Greendale GA, Sternfeld B, Huang MH, Han W, Karvonen-Gutierrez C, Ruppert K, et al. Changes in body composition and weight during the menopause transition. JCI Insight;4. Epub ahead of print 2019. DOI:10.1172/JCI.INSIGHT.124865.
  52. Ambikairajah A, Walsh E, Tabatabaei-Jafari H, Cherbuin N. Fat mass changes during menopause: a metaanalysis. Am J Obstet Gynecol 2019;221:393-409.e50.
  53. Baker JF, Long J, Ibrahim S, Leonard MB, Katz P. Men Are at Greater Risk of Lean Mass Deficits in Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 2015;67:112.
  54. Tengstrand B, Carlström K, Hafström I. Gonadal hormones in men with rheumatoid arthritis--from onset through 2 years. J Rheumatol 2009;36:887-92.
  55. Rivier C. Neuroendocrine Effects of Cytokines in the Rat. Rev Neurosci 1993;4:223-38.
  56. Rivier C, Vale W. In the rat, interleukin-1 alpha acts at the level of the brain and the gonads to interfere with gonadotropin and sex steroid secretion. Endocrinology 1989;124:2105-9.
  57. Cutolo M, Straub RH. Sex steroids and autoimmune rheumatic diseases:state of the art. Nat Rev Rheumatol 2020;16:628-44.
  58. Cutolo M, Wilder RL. Different roles for androgens and estrogens in the susceptibility to autoimmune rheumatic diseases. Rheum Dis Clin North Am 2000;26:825-39.
  59. Schmidt M, Kreutz M, Löffler G, Schölmerich J, Straub RH. Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages. J Endocrinol 2000;164:161-9.
  60. Castagnetta LA, Carruba G, Granata OM, Stefano R, Miele M, Schmidt M, et al. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J Rheumatol 2003;30:2597-605.
  61. Fukuda W, Omoto A, Oku S, Tanaka T, Tsubouchi Y, Kohno M, et al. Contribution of rheumatoid arthritis disease activity and disability to rheumatoid cachexia. Mod Rheumatol 2010;20:439-43.
  62. Uutela TI, Kautiainen HJ, Häkkinen AH. Decreasing muscle performance associated with increasing disease activity in patients with rheumatoid arthritis. PLoS One 2018;13:e0194917.
  63. Summers GD, Deighton CM, Rennie MJ, Booth AH. Rheumatoid cachexia: a clinical perspective. Rheumatology (Oxford) 2008;47:1124-31.
  64. Costamagna D, Costelli P, Sampaolesi M, Penna F. Role of Inflammation in Muscle Homeostasis and Myogenesis. Mediators Inflamm; 2015. Epub ahead of print 2015. DOI:10.1155/2015/805172.
  65. Marcora SM, Chester KR, Mittal G, Lemmey AB, Maddison PJ. Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. Am J Clin Nutr 2006;84:1463-72.
  66. Matschke V, Murphy P, Lemmey AB, Maddison P, Thom JM. Skeletal muscle properties in rheumatoid arthritis patients. Med Sci Sports Exerc 2010;42:2149-55.
  67. Masuko K. Rheumatoid Cachexia Revisited: A Metabolic Co-Morbidity in Rheumatoid Arthritis. Front Nutr 2014;1:20.
  68. Elkan AC, Håkansson N, Frostegård J, et al. Low level of physical activity in women with rheumatoid arthritis is associated with cardiovascular risk factors but not with body fat mass - A cross sectional study. BMC Musculoskelet Disord 2011;12:1-6.
  69. Matschke V, Murphy P, Lemmey AB, Maddison PJ, Thom JM. Muscle quality, architecture, and activation in cachectic patients with rheumatoid arthritis. J Rheumatol 2010;37:282-4.
  70. Giles JT, Bartlett SJ, Andersen RE, Fontaine KR, Bathon JM. Association of body composition with disability in rheumatoid arthritis: impact of appendicular fat and lean tissue mass. Arthritis Rheum 2008;59:1407-1415.
  71. Chatzidionysiou K, Sfikakis PP. Low rates of remission with methotrexate monotherapy in rheumatoid arthritis:review of randomised controlled trials could point towards a paradigm shift. RMD Open 2019;5:e000993.
  72. National Guideline Centre. Rheumatoid arthritis in adults:diagnosis and management. London:National Institute for Health and Care Excellence (UK), 2018.
  73. Ter Borg S, de Groot LC, Mijnarends DM, de Vries JH, Verlaan S, Meijboom S, et al. Differences in Nutrient Intake and Biochemical Nutrient Status Between Sarcopenic and Nonsarcopenic Older Adults-Results From the Maastricht Sarcopenia Study. J Am Med Dir Assoc 2016;17:393-401.
  74. Kado DM, Bucur A, Selhub J, Rowe JW, Seeman T. Homocysteine levels and decline in physical function: MacArthur Studies of Successful Aging. Am J Med 2002;113:537-42.
  75. Morgan SL, Baggott JE. Folate supplementation during Methotrexate therapy for rheumatoid arthritis. Clin Exp Rheumatol 2010;28:S102-S109.
  76. Chen C-Y, Tsai C-Y, Lee P-C, Lee S-D. Long-term etanercept therapy favors weight gain and ameliorates cachexia in rheumatoid arthritis patients:roles of gut hormones and leptin. Curr Pharm Des 2013;19:1956-64.
  77. Engvall IL, Tengstrand B, Brismar K, Hafström I. Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin:a randomised study over 21 months. Arthritis Res Ther 2010;12:R197.
  78. Serelis J, Kontogianni MD, Katsiougiannis S, Bletsa M, Tektonidou MG, Skopouli FN. Effect of anti-TNF treatment on body composition and serum adiponectin levels of women with rheumatoid arthritis. Clin Rheumatol 2008;27:795-7.
  79. Toussirot É, Mourot L, Dehecq B, Wendling D, Grandclément É, Dumoulin G, et al; CBT-506. TNFα blockade for inflammatory rheumatic diseases is associated with a significant gain in android fat mass and has varying effects on adipokines: a 2-year prospective study. Eur J Nutr 2014;53:951-61.
  80. Baker JF, Cannon GW, Ibrahim S, Haroldsen C, Caplan L, Mikuls TR. Predictors of longterm changes in body mass index in rheumatoid arthritis. J Rheumatol 2015;42:920-7.
  81. Hernandez-Baldizon S. [How to effectively use methotrexate in rheumatoid arthritis?]. Reumatol Clin 2012;8:42-5.
  82. Tian H, Cronstein BN. Understanding the mechanisms of action of methotrexate:implications for the treatment of rheumatoid arthritis - PubMed. Bull NYU Hosp Jt Dis 2007;65:168-73.
  83. Tournadre A, Pereira B, Dutheil F, Giraud C, Courteix D, Sapin V, et al. Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis. J Cachexia Sarcopenia Muscle 2017;8:639-46.
  84. Toussirot E, Marotte H, Mulleman D, Cormier G, Coury F, Gaudin P, et al. Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study. Arthritis Res Ther 2020;22:224.
  85. Schultz O, Oberhauser F, Saech J, Rubbert-Roth A, Hahn M, Krone W, et al. Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases. PLoS One;5. Epub ahead of print 2010. DOI:10.1371/JOURNAL.PONE.0014328.
  86. Hoffman E, Rahat MA, Feld J, Atha J, Sieren JC, Samei E, et al. Effects of tocilizumab, an anti-interleukin-6 receptor antibody, on serum lipid and adipokine levels in patients with rheumatoid arthritis. Int J Mol Sci;20. Epub ahead of print 2 September 2019. DOI:10.3390/ijms20184633.
  87. Comee L, Taylor CA, Nahikian-Nelms M, Ganesan LP, Krok-Schoen JL. Dietary patterns and nutrient intake of individuals with rheumatoid arthritis and osteoarthritis in the United States. Nutrition 2019;67-68:110533.
  88. Markaki AG, Gkiouras K, Papakitsos C, Grammatikopoulou MG, Papatsaraki A, Ioannou R, et al. Disease Activity, Functional Ability and Nutritional Status in Patients with Rheumatoid Arthritis: An Observational Study in Greece. Mediterr J Rheumatol 2020;31:406.
  89. Standley KN, Gjertsson I, Winkvist A, Lindqvist HM. Dietary Habits of Women with Rheumatoid Arthritis Differ from that of Women without the Disease: Results from a Population-Based Study. J Rheum Dis Treat 2019;5:072.
  90. Stone J, Doube A, Dudson D, Wallace J. Inadequate calcium, folic acid, vitamin E, zinc, and selenium intake in rheumatoid arthritis patients: results of a dietary survey. Semin Arthritis Rheum 1997;27:180-5.
  91. Kremer JM, Bigaouette J. Nutrient intake of patients with rheumatoid arthritis is deficient in pyridoxine, zinc, copper, and magnesium - PubMed. J Rheumatol 1996;23:990-994.
  92. Gioia C, Lucchino B, Tarsitano MG, Iannuccelli C, Di Franco M. Dietary Habits and Nutrition in Rheumatoid Arthritis: Can Diet Influence Disease Development and Clinical Manifestations? Nutrients;12. Epub ahead of print 1 May 2020. DOI:10.3390/NU12051456.
  93. Kelepouri D, Mavropoulos A, Bogdanos DP, Sakkas LI. The Role of Flavonoids in Inhibiting Th17 Responses in Inflammatory Arthritis. J Immunol Res;2018. Epub ahead of print 2018. DOI:10.1155/2018/9324357.
  94. Wilkinson TJ, Lemmey AB, Jones JG, Sheikh F, Ahmad YA, Chitale S, et al. Can Creatine Supplementation Improve Body Composition and Objective Physical Function in Rheumatoid Arthritis Patients? A Randomized Controlled Trial. Arthritis Care Res (Hoboken) 2016;68:729-37.
  95. Marcora S, Lemmey A, Maddison P. Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine:a randomised controlled trial. Clin Nutr 2005;24:442-454.
  96. Aryaeian N, Sedehi SK, Khorshidi M, Zarezadeh M, Hosseini A, Shahram F. Effects of hydroalcoholic extract of Berberis Integerrima on the anthropometric indices and metabolic profile in active rheumatoid arthritis patients. Complement Ther Med 2020;50:102331.
  97. Lovell DJ, Glass D, Ranz J, Kramer S, Huang B, Sierra RI, et al. A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis. Arthritis Rheum 2006;54:2235-42.
  98. Jia H, Wen Y, Aw W, Jia Q. Ameliorating Effects of Coriander on Gastrocnemius Muscles Undergoing Precachexia in a Rat Model of Rheumatoid Arthritis: A Proteomics Analysis. Nutr 2021, Vol 13, Page 4041 2021;13:4041.
  99. Spies CM, Straub RH, Buttgereit F. Energy metabolism and rheumatic diseases:From cell to organism. Arthritis Res Ther 2012;14:1-10.
  100. Nutsch K, Hsieh C. When T cells run out of breath:the HIF-1α story. Cell 2011;146:673-674.
  101. Procaccini C, Galgani M, De Rosa V, Matarese G. Intracellular metabolic pathways control immune tolerance. Trends Immunol 2012;33:1-7.
  102. Lacourt TE, Vichaya EG, Chiu GS, Dantzer R, Heijnen CJ. The high costs of low-grade inflammation: Persistent fatigue as a consequence of reduced cellular-energy availability and non-adaptive energy expenditure. Front Behav Neurosci 2018;12:78.
  103. Liu TF, Vachharajani VT, Yoza BK, McCall CE. NAD+-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response. J Biol Chem 2012;287:25758-69.
  104. Chimenti MS, Triggianese P, Conigliaro P, Candi E, Melino G, Perricone R. The interplay between inflammation and metabolism in rheumatoid arthritis. Cell Death Dis 2015 69 2015;6:e1887-e1887.
  105. Reid MB, Li YP. Tumor necrosis factor-α and muscle wasting:a cellular perspective. Respir Res 2001;2:269.
  106. Laviano A, Koverech A, Mari A. Cachexia: clinical features when inflammation drives malnutrition. Proc Nutr Soc 2015;74:348-354.
  107. Binymin K, Herrick AL, Carlson GL, Hopkins S. The effect of disease activity on body composition and resting energy expenditure in patients with rheumatoid arthritis. J Inflamm Res 2011;4:61-66.
  108. Roubenoff R, Walsmith J, Lundgren N, Snydman L, Dolnikowski GJ, Roberts S. Low physical activity reduces total energy expenditure in women with rheumatoid arthritis:implications for dietary intake recommendations. Am J Clin Nutr 2002;76:774-9.
  109. Straub RH. The brain and immune system prompt energy shortage in chronic inflammation and ageing. Nat Rev Rheumatol 2017 1312 2017;13:743-751.
  110. Tierney M, Fraser A, Purtill H, Kennedy N. Profile of energy expenditure in people with rheumatoid arthritis. Disabil Health J 2015;8:514-520.
  111. Arshad A, Rashid R, Benjamin K. The effect of disease activity on fat-free mass and resting energy expenditure in patients with rheumatoid arthritis versus noninflammatory arthropathies/soft tissue rheumatism. Mod Rheumatol 2014;17:470-75.
  112. Choe JY, Park SH, Lee H, Kwon HH, Kim SK. Resting energy expenditure is not associated with disease activity in women with rheumatoid arthritis: cross-sectional study. Korean J Intern Med 2014;29:516.
  113. Metsios GS, Stavropoulos-Kalinoglou A, Panoulas VF, Koutedakis Y, Nevill AM, Douglas KM, et al. New resting energy expenditure prediction equations for patients with rheumatoid arthritis. Rheumatology (Oxford) 2008;47:500-6.
  114. Elkan A-C, Engvall I-L, Tengstrand B, Cederholm T, Hafström I. Malnutrition in women with rheumatoid arthritis is not revealed by clinical anthropometrical measurements or nutritional evaluation tools. Eur J Clin Nutr 2008;62:1239-47.
  115. Paget J. Nervous mimicry of organic diseases. Lancet 1873;ii:727-29.
  116. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. ARTHRITIS Rheum 2010;62:2569-81.
  117. Piccoli A, Nescolarde LD, Rosell J. Análisis convencional y vectorial de bioimpedancia en la práctica clínica. NEFROLOGÍA 2002;XXII:228-38.
  118. Boers M, Verhoeven AC, Markusse HM, Westhovens R, van Denderen JC, van Zeben D, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet (London, England) 1997;350:309-18.